Autres langues Zydus Lifesciences Limited

Actions

ZYDUSLIFE

INE010B01027

Marché Fermé - NSE India S.E. Autres places de cotation 13:43:50 19/04/2024			Varia. 5j.	Varia. 1 janv.
922,2 ^INR	-1,58 %		-4,16 %	+33,80 %

01/04	Zydus reçoit l'approbation de l'OMS pour la dénomination commune internationale de l'Usnoflast en tant que nom recommandé pour ZYIL1	CI
28/03	Zydus reçoit quatre observations de la FDA pour son usine de produits injectables en oncologie	MT

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Zydus Receives Approval from WHO International Non-Proprietary Names for Usnoflast as Recommended Name for ZYIL1	01/04
Zydus Gets Four Observations from US FDA for Oncology Injectable Plant	28/03
Zydus Lifesciences Limited Receives Tentative Approval from USFDA for Letermovir Tablets, 240 Mg and 480 Mg	23/03
Zydus Lifesciences Gets US FDA's Final Nod for Finasteride and Tadalafil Capsules	18/03
Zydus Lifesciences Limited Receives Final Approval from USFDA and 180 Days CGT Exclusivity for Finasteride and Tadalafil Cap Capsules	16/03
Tranche Update on Zydus Lifesciences Limited's Equity Buyback Plan announced on February 9, 2024.	15/03
Zydus Lifesciences Gets US FDA Final Nod for Chlorpromazine Hydrochloride Injection; Shares Jump 3%	14/03
Zydus Receives Final Approval from the USFDA for Chlorpromazine Hydrochloride Injection USP, 25 mg/mL and 50 mg/2 mL (25 mg/mL), Single-Dose Vials	14/03
Zydus Receives Tentative Approval from the USFDA for Edaravone Injection, 30 mg/100 mL (0.3 mg/mL), Single-Dose Vial	14/03
Zydus Lifesciences Launches Generic Cancer Drug Ibyra in India	13/03
Zydus Lifesciences Limited Launches IBYRA, the Generic Version of Olaparib	13/03
Zydus Lifesciences Gets US FDA's EIR for Ahmedabad, India Unit's Inspection	11/03
Zydus Lifesciences Limited's Equity Buyback announced on February 9, 2024, has closed with 5,970,149 shares, representing 0.59% for INR 6,000 million.	06/03
EXCLUSIVA-Eli Lilly podría lanzar un fármaco contra la obesidad en India el próximo año: presidente ejecutivo	28/02
Zydus Lifesciences Forms UAE-Based Arm	23/02
Zydus Lifesciences Limited Announces Incorporation of Wholly Owned Subsidiary Company	22/02
Zydus Lifesciences Gets US FDA Final Approval for Generic Chest Pain Drug	16/02
Zydus Lifesciences Limited Receives Final Approval from the United States Food and Drug Administration for Isosorbide Mononitrate Extended-Release, Tablets USP, 30 mg, 60 mg, and 120 mg	16/02
Zydus Lifesciences' Consolidated Net Profit Increases in Fiscal Q3; Shares Jump 7%	12/02
Zydus Lifesciences Gets Tentative US FDA Approval for Dexamethasone	09/02

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Zydus Lifesciences Limited

Actions

ZYDUSLIFE

INE010B01027

Autres langues

Filtres